Comments
Hester Biosciences Ltd has registered net profit of Rs 2.74 crore for the quarter ended September 2014 against Rs 1.65 crore in the corresponding quarter in the previous year, showing a growth of 67 per cent. Company’s net sales during the quarter grew by 41 per cent to Rs 21.49 crore from Rs 15.29 crore in the same period previous year. The company has shown improvement in the EPS for the quarter at Rs 3.22 as against Rs 1.94 in the corresponding quarter last year, a company statement said.
For the first half period of the fiscal, Hester reported net profit of Rs 7.08 crore as against Rs 3.63 crore in the corresponding period last year. Net sales for the period stood at Rs 44.79 crore as compared to Rs 31.34 crore for the previous corresponding period.
Rajiv Gandhi, CEO & Managing Director, said that all financial targets of first half have been met. “Three verticals (i.e. Poultry vaccines, Poultry Health Products & Large Animal Health Products) have shown a sizable improvement in top line & in bottom line. Business in the fourth vertical – Large Animal vaccines, will commence in the last quarter of this financial year.
Company shares ended negative at Rs 332 down by 2.58 per cent from previous close on the Bombay Stock Exchange (BSE) on Tuesday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.